Background & Aims: Sarcopenia, frailty, and COVID-19 appear to be intertwined. Preventive and intervention measures are required to break this link and mitigate the consequences of rising morbidity and mortality among older adults. This study aimed to identify and synthesize important factors related to the interaction of the devastating trio and their impact on the health and mortality of older adults.
Methods: Data were gathered via searches of PubMed, Cochrane Library, Google Scholar, and Elsevier Mendeley Website. Study selection and data extraction were conducted by the two authors independently. The primary outcome was mortality, secondary outcomes included hospitalization and risk of development of severe disease among older Covid-19 patients. The study results are presented as adjusted odds and hazard ratios with 95% CI.
Results: A total of 1725 studies were identified through our electronic databases searches. After screening and assessing for eligibility, 39 studies were included in this review, a total of 51,796 patients were included in the systematic review. Our results indicated that frail patients recorded a higher mean age compared to non-frail patients (p < 0.00001), and COVID-19 frail patients had significantly increased mortality rate compared to non-frail patients, the log adjusted OR was 2.10 (1.63, 2.71); I = 78%; p < 0.00001.
Conclusion: Age and frailty are important risk factors for mortality among older adults COVID-19 patients. COVID-19 patients with sarcopenia had a higher risk of developing severe conditions, including hospitalization and ICU admission. Findings that support the use of frailty and sarcopenia indicators to help in the decision-making process for medical care in older adults COVID-19 patients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356632 | PMC |
| http://dx.doi.org/10.1016/j.clnesp.2022.07.015 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Background: Over the past several decades, the overweight and obesity epidemic in the USA has resulted in a significant health and economic burden. Understanding current trends and future trajectories at both national and state levels is crucial for assessing the success of existing interventions and informing future health policy changes. We estimated the prevalence of overweight and obesity from 1990 to 2021 with forecasts to 2050 for children and adolescents (aged 5-24 years) and adults (aged ≥25 years) at the national level.
View Article and Find Full Text PDFArticle Synopsis
- * The study analyzed over 11,000 sources to assess stillbirth rates across 204 countries from 1990 to 2021, using varied definitions and gestational age benchmarks for clarity.
- * In 2021, the global stillbirth rate was 23.0 per 1,000 births at 20 weeks or longer, with a neonatal mortality rate of 17.1 per 1,000 live births, indicating a concerning level of both stillbirths and neonatal deaths worldwide.
SPTLC2 variants are associated with early-onset ALS and FTD due to aberrant sphingolipid synthesis.
Ann Clin Transl Neurol
April 2024
Department of Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Article Synopsis
- The study focused on understanding the genetic basis of early-onset ALS, a severe neurodegenerative disease, by analyzing families with members diagnosed before the age of 40.
- Research methods included whole-exome sequencing and biochemical assessments, leading to the identification of gene variants in SPTLC2 that are linked to elevated sphingolipid production in early-onset ALS patients.
- Findings suggest a connection between specific genetic mutations and disrupted sphingolipid metabolism, contributing to ALS development and highlighting the genetic complexity of the disease.
TRIOBP modulates β-catenin signaling by regulation of miR-29b in idiopathic pulmonary fibrosis.
Cell Mol Life Sci
December 2023
State Key Laboratory of Cell Differentiation and Regulation; Henan International Joint Laboratory of Pulmonary Fibrosis; Henan Center for Outstanding Overseas Scientists of Organ Fibrosis; College of Life Science, Henan Normal University, 46 Jianshe Road, Xinxiang, 453007, Henan, China.
Idiopathic pulmonary fibrosis (IPF) is a fatal and devastating lung disease of unknown etiology, described as the result of multiple cycles of epithelial cell injury and fibroblast activation. Despite this impressive increase in understanding, a therapy that reverses this form of fibrosis remains elusive. In our previous study, we found that miR-29b has a therapeutic effect on pulmonary fibrosis.
View Article and Find Full Text PDFIdentification of a Novel Non-Canonical Splice-Site Variant in .
J Clin Med
January 2023
Department of Pediatrics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China.
Cerebral adrenoleukodystrophy (CALD) is a fatal genetic disease characterized by rapid, devastating neurological decline, with a narrow curative treatment window in the early stage. Non-canonical splice-site (NCSS) variants can easily be missed during genomic DNA analyses, and only a few of them in have been explored. Here, we studied a Chinese patient with clinical features similar to those of early-stage CALD but with a negative molecular diagnosis and a sibling who had presumably died of CALD.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!